Presented by BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster representing more than 220 member organizations, Illumina VP & Distinguished Scientist Dr. Gary Schroth will provide a short overview of genomic surveillance implications on vaccine efficacy.

Sequencing-based surveillance helps public health officials track the path of the epidemic, understand transmission routes, determine the rate of viral evolution, and understand if the virus is changing in ways that impact therapeutic effectiveness. As a leader in next-generation sequencing, Illumina is working with researchers around the world to provide the vital capacity needed for a data-driven response.

Register here:

Print Friendly, PDF & Email